Northera Payer Strategy

Discussion in 'Lundbeck' started by anonymous, Apr 25, 2018 at 8:06 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I’m by nature a very positive person but I’m really starting to sour. Sick of working to get writers to try Northera only for them to start the perfect candidate and then have the patient cancel due to lack of financial support. Dual-eligible, LIS and commercial patients isn’t a strategy - it’s a move of desperation. I’m really close to leaving as I can’t invest my hard efforts only to see the company’s strategy let me down. This needs to be fixed yesterday
     

  2. anonymous

    anonymous Guest

    Yes we all our sick of it. I had a a cardio who stooped writing in November ( yes the co pay was the issue) when he had to DC a few patients who were doing great with Northera. Well he put the pen to the pad, less then two weeks ago. I received a call yesterday and was informed that the co-pay was 1700. The nurse then went on to say the doc has canceled all my lunches. He never want to hear about Northera again. He also was calling home office.
     
  3. anonymous

    anonymous Guest

    Been in this game for years. Those that can’t sell bitch about co-pays, Managed Care, access, etc. Those of us that are pro’s make it happen!
     
  4. anonymous

    anonymous Guest

    Spoken like a ASM who leads from behind. Well done. Bravo.
     
  5. anonymous

    anonymous Guest

    home office picks winners and losers in the field with this drug. Vanderbilt comes to mind
     
  6. anonymous

    anonymous Guest

    The problem isn’t making it happen. We’re all capable sales people. The problem is standing in front of a KOL and asking them to cherry pick patients who are appropriate for Northera based on their insurance. Physicians don’t think this way and you can’t expect them to respect this tactic. It makes us look bad.
     
  7. anonymous

    anonymous Guest

    This drug has existed for decades. Some would say it’s unethical to have insurance dictate who has access.

    You are gouging patients for every cent their insurance can tolerate. The same thing was done with Sabril and Xenazine.